LETTER
Synthesis of the C1–C10–C5 Fragment of FR225654
2585
mixture of t-BuOH–H2O (10 mL) at 0 °C. The reaction
mixture was stirred at 0 °C and monitored by TLC. Upon
completion, the reaction mixture was quenched with solid
Na2SO3 (1.5 g), warmed to r.t., and stirred for an additional
60 min. The product was extracted with EtOAc, washed with
brine, dried over MgSO4, concentrated, and purified on silica
gel to afford an inseparable mixture of the required diol and
the corresponding diastereomer.
gands. Noteworthy, with the PMP protecting group, the
reaction rate is significantly increased. Finally, an effec-
tive application to the stereoselective synthesis of the
C1–C10–C5 fragment of FR225654 has been achieved.
Acknowledgment
Spectroscopic Data of Diol 14 (Major Isomer)
1H NMR (300 MHz, CDCl3): δ = 7.26 (d, J = 8.6 Hz, 2 H),
6.89 (d, J = 8.6 Hz, 2 H), 4.47 (s, 2 H), 3.80 (s, 3 H), 3.42
(dd, J = 4.2, 9.0 Hz, 1 H), 3.38 (d, J = 12.0 Hz, 1 H), 3.32 (d,
J = 12.0 Hz, 1 H), 3.21 (m, 1 H), 2.11 (m, 1 H), 1.68 (dd, J
= 7.8, 14.6 Hz, 1 H), 1.36 (dd, J = 3.3, 14.6 Hz, 1 H), 1.16 (s,
3 H), 0.93 (d, J = 6.9 Hz, 3 H) ppm. 13C NMR (75 MHz,
CDCl3): δ = 159.1, 12 9.3, 113.7, 76.6, 72.8, 71.8, 70.9,
55.0, 4 4.3, 28.6, 23.5, 19.5 ppm.
We gratefully acknowledge MENRT for a fellowship awarded to
S.M.
Supporting Information for this article is available online at
m
iotSrat
ungIifoop
r
t
References and Notes
Spectroscopic Data of Diol 16 (Minor Isomer)
1H NMR (300 MHz, CDCl3): δ = 7.26 (d, J = 8.6 Hz, 2 H),
6.89 (d, J = 8.6 Hz, 2 H), 4. 46 (s, 2 H ), 3.80 (s, 3 H), 3.48
(m, 1 H), 3.38 (d, J = 11.0 Hz, 1 H), 3.32 (d, J = 11.0 Hz, 1
H), 3.19 (m, 1 H), 1.95 (m, 1 H), 1.63 (dd, J = 6.0, 14.4 Hz,
1 H), 1.45 (dd, J = 4.8, 14.4 Hz, 1 H), 1.16 (s, 3 H), 0.95 (d,
J = 6 . 9 Hz, 3 H) ppm. 13C NMR (75 MHz, CDCl3) δ =
159.1, 129.3, 113.7, 76.4, 72.6, 71.8, 69.0, 55.0, 44.0, 29.1,
24.3, 19.3 ppm. IR (neat): ν = 3360, 2932, 1611, 1513, 1462,
1246, 1033, 819, 771 cm–1. ESI-HRMS: m/z calcd for
C15H24NaO4+ [MNa+]: 291.1567; found: 291.1570.
For spectroscopic data of all diols, see the Supporting
Information.
(1) (a) Takase, S.; Shibata, T.; Hino, M.; Nakajima, H.
J. Antibiot. 2005, 58, 447. (b) Ohtsu, Y.; Sasamura, H.;
Shibata, T.; Hino, M.; Nakajima, H. J. Antibiot. 2005, 58,
452. (c) Ohtsu, Y.; Yoshimura, S.; Kinoshita, T.; Takase, S.;
Nakajima, H. J. Antibiot. 2005, 58, 479.
(2) For erythronolide, see for instance: (a) McGuire, J. M.;
Bunch, R. L.; Anderson, R. C.; Boaz, H. E.; Flynn, E. H.;
Powell, H. M.; Smith, J. W. Antibiot. Chemother. 1952, 2,
281. For lankanolide and lankamycin, see: (b) Keller-
Schierlein, W.; Roncari, G. Helv. Chim. Acta 1962, 45, 138.
(c) Gäumann, E.; Hütter, R.; Keller-Schierlein, W.; Neipp,
L.; Prelog, V.; Zahner, H. Helv. Chim. Acta 1960, 43, 601.
For ent-homoabyssomycin, see: (d) Abdalla, M. A.; Yadav,
P. P.; Dittrich, B. A.; Schüffler, A.; Laatsch, H. Org. Lett.
2011, 13, 2156.
(3) (a) Kolb, H. C.; VanNieuwenhze, M. S.; Sharpless, K. B.
Chem. Rev. 1994, 94, 2483. (b) Kolb, H. C.; Sharpless, K. B.
In Transition Metals for Organic Synthesis; Vol. 2; Beller,
M.; Bolm, C., Eds.; Wiley-VCH: Weinheim, 2004.
(4) A single synthesis of triol 4 has been reported: Thomas, E.
J.; Whitehead, J. W. F. J. Chem. Soc., Perkin Trans. 1 1989,
507.
(5) For the synthesis of olefin 5, see for instance: (a) Evans, D.
A.; Polniaszek, R. P.; DeVries, K. M.; Guinn, D. E.; Mathre,
D. J. J. Am. Chem. Soc. 1991, 113, 7613. (b) Tan, Z.; Liang,
B.; Huo, S.; Shi, J.-c.; Negishi, E.-i. Tetrahedron:
Asymmetry 2006, 17, 512. (c) Trost, B. M.; Michaelis, D. J.;
Charpentier, J.; Xu, J. Angew. Chem. Int. Ed. 2012, 51, 204.
(6) (a) Theurer, M.; Fischer, P.; Baro, A.; Nguyen, G.-S.;
Kourist, R.; Bornscheuer, U.; Laschat, S. Tetrahedron 2010,
66, 3814. (b) Donohoe, T. J.; Johnson, P. D.; Pye, R. J.;
Keenan, M. Org. Lett. 2005, 7, 1275. (c) Donohoe, T. J.
Synlett 2002, 1223.
(11) For the synthesis of (S)- and (R)-iodides 13, see for instance:
(a) Heckrodt, T. J.; Mulzer, J. Synthesis 2002, 1857.
(b) Haslett, G. W.; Paterson, I. Org. Lett. 2013, 15, 1338.
(c) For the typical procedure and spectroscopic data of
substrates, see the Supporting Information.
(12) (a) Wang, Y.; Dong, X.; Larock, R. C. J. Org. Chem. 2003,
68, 3090. (b) Hareau, G. P.-J.; Koiwa, M.; Hikichi, S.; Sato,
F. J. Am. Chem. Soc. 1999, 121, 3640.
(13) For analytical data for 12 and 13, see the Supporting
Information.
(14) For the osmylation of (R)- and (S)-12 and (R)- and (S)-13 in
the absence of chiral ligands, see general procedure (ref. 10),
however, without ligand.
(15) Analytical Data for 25
1H NMR (400 MHz, CDCl3): δ = 4.28–4.01 (br s, 2 H), 3.56
(dd, J = 3.6, 10.5 Hz, 1 H), 3.27 (dd, J = 9.0, 10.5 Hz, 1 H),
2.40 (d, J = 16.8 Hz, 1 Hz), 2.33 (d, J = 16.8 Hz, 1 H), 1.93
(m, 1 H), 1.58 (m, 2 H), 1.28 (s, 3 H), 0.86 (d, J = 6.9 Hz, 3
H), 0.13 (s, 9 H) ppm. 13C NMR (100 MHz, CDCl3): δ =
103.7, 87.9, 71.7, 68.9, 47.3, 36.1, 31.8, 25.4, 19.6, 0.1 ppm.
IR (neat): ν = 3276, 2958, 2927, 2175, 1460, 1423, 1376,
1248, 1032, 758 cm–1. ESI-HRMS: m/z calcd for
C12H24NaO2Si+ [MNa+]: 251.1438; found: 251.1439. The
relative configuration of 25 was confirmed by NMR
experiments (NOESY analysis) of the corresponding γ-
lactone (Figure 2).
(7) Corey, E. J.; Noe, M. C.; Ting, A. Y. Tetrahedron Lett. 1996,
37, 1735.
(8) (a) Bondar, D.; Liu, J.; Müller, T.; Paquette, L. A. Org. Lett.
2005, 7, 1813. (b) In another paper, SAD of tert-
butyltrimethylsilyl ether protected 4-methylpent-4-en-1-ol
was reported, however, without mention of the ee of the
resulting diol: O’Connor, P. D.; Knight, C. K.; Friedrich, D.;
Peng, X.; Paquette, L. A. J. Org. Chem. 2007, 72, 1747.
(9) Lorenz, M.; Kalesse, M. Org. Lett. 2008, 10, 4371.
(10) Typical Procedure for the Sharpless Asymmetric
Dihydroxylation
H3C
O
H
H
O
NOE
H
H3C
K2CO3 (415 mg, 3 mmol), K3Fe(CN)6 (1.18 g, 3 mol),
K2OsO2(OH)4 (4 mg, 0.01 mmol), ligand (0.025 mol), and
MeSO2NH2 (95 mg, 1 mmol) were added to a vigorously
magnetically stirred solution of olefin (1 mmol) in a 1:1
TMS
Figure 2
© Georg Thieme Verlag Stuttgart · New York
Synlett 2013, 24, 2581–2585